AbbVie is a global biopharmaceutical leader with approximately 55,000 employees in over 70 countries. In 2024, the company invested over $10.8 billion in research and development, supporting active immunology, oncology, and neuroscience clinical programs. To accelerate drug discovery, AbbVie is applying artificial intelligence (AI) to improve early-stage decision-making. The company…